| Terminated | A Study of DS-1471a In Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-08-04 |
| Completed | Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced Gastric Cancer | — | 2023-03-09 |
| Completed | Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects Respiratory Syncytial Virus Infections | Phase 1 | 2021-06-11 |
| Completed | Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects Fibrodysplasia Ossificans Progressiva | Phase 1 | 2021-04-01 |
| Active Not Recruiting | A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan Tenosynovial Giant Cell Tumor | Phase 2 | 2021-03-15 |
| Completed | Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects Covid19 | Phase 1 / Phase 2 | 2021-03-15 |
| Active Not Recruiting | A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT Tenosynovial Giant Cell Tumor | Phase 3 | 2020-09-25 |
| Completed | A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Hea Healthy Subjects, Drug-drug Interaction, Pharmacokinetics | EARLY_Phase 1 | 2020-08-28 |
| Completed | A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Partici Healthy Subjects, Drug-drug Interaction, Pharmacokinetics | Phase 1 | 2020-08-19 |
| Active Not Recruiting | A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma WHO Grade II Glioma | Phase 2 | 2020-07-08 |
| Active Not Recruiting | Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy | Phase 2 | 2020-06-30 |
| Terminated | Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2020-01-13 |
| Completed | Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma Adult T-cell Leukemia/Lymphoma | Phase 2 | 2019-11-21 |
| Completed | A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patien Diabetic Peripheral Neuropathic Pain | Phase 3 | 2019-09-18 |
| Completed | Study of Mirogabalin for Central Neuropathic Pain Central Neuropathic Pain | Phase 3 | 2019-03-12 |
| Completed | Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Acute Myeloid Leukemia (AML) | Phase 1 | 2018-11-05 |
| Terminated | DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Smal Non Small Cell Lung Cancer | Phase 1 | 2018-09-21 |
| Completed | Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 1 | 2018-08-23 |
| Completed | DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) Colorectal Neoplasm | Phase 2 | 2018-02-23 |
| Active Not Recruiting | First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, Non-small Cell Lung Cancer | Phase 1 | 2018-01-31 |
| Completed | Study of DS-8201a for Participants With Advanced Solid Malignant Tumors Neoplasm Metastasis | Phase 1 | 2018-01-12 |
| Completed | Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressin Malignant Neoplasm of Breast | Phase 1 | 2017-12-26 |
| Completed | DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] Neoplasm, Gastrointestinal | Phase 2 | 2017-11-02 |
| Completed | Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy Acute Ischemic Stroke | N/A | 2017-07-30 |
| Completed | A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma Melanoma | N/A | 2017-01-31 |
| Completed | Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplicatio Leukemia, Myeloid, Acute | Phase 2 | 2016-12-08 |
| Completed | Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastat Metastatic Breast Cancer | Phase 1 / Phase 2 | 2016-11-28 |
| Completed | Study of CS-3150 in Patients With Essential Hypertension Essential Hypertension | Phase 3 | 2016-09-01 |
| Completed | Study of CS-3150 in Patients With Primary Aldosteronism Primary Aldosteronism | N/A | 2016-09-01 |
| Completed | Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 1 | 2016-08-12 |
| Completed | Study of DU-176b Aged 80 Years or Older Atrial Fibrillation | Phase 3 | 2016-08-05 |
| Completed | Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension Essential Hypertension | N/A | 2016-08-01 |
| Completed | Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairm Hypertension With Moderate Renal Impairment | Phase 3 | 2016-06-01 |
| Completed | Study of CS-3150 in Patients With Severe Hypertension Severe Hypertension | Phase 3 | 2016-06-01 |
| Completed | Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2016-06-01 |
| Completed | Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria Hypertension | Phase 3 | 2016-06-01 |
| Active Not Recruiting | DS-3201b in Participants With Lymphomas Lymphoma, Malignant, Non-hodgkin Lymphoma | Phase 1 | 2016-03-31 |
| Completed | Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patie Essential Hypertension | Phase 3 | 2016-03-01 |
| Completed | Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors Advanced Solid Malignant Tumors | Phase 1 | 2016-02-10 |
| Completed | Phase 1 Study of Quizartinib Relapsed AML, Refractory AML | Phase 1 | 2016-02-01 |
| Completed | Study of DS-1123a in Advanced Solid Tumours Advanced Solid Malignant Tumors | Phase 1 | 2016-01-01 |
| Completed | A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin Type 2 Diabetes Mellitus | Phase 2 | 2016-01-01 |
| Completed | An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp Type 2 Diabetes Mellitus | N/A | 2016-01-01 |
| Completed | DS-5565 Phase III Study for Renal Impairment in Japanese Subjects Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia | Phase 3 | 2015-12-01 |
| Completed | A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM) Type2 Diabetes Mellitus | N/A | 2015-11-01 |
| Completed | Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | 2015-10-01 |
| Completed | Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors Advanced Solid Tumors | Phase 1 | 2015-09-01 |
| Completed | DS-5565 Phase III Study for Post-herpetic Neuralgia Post-Herpetic Neuralgia | N/A | 2015-01-01 |
| Completed | DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain Diabetic Peripheral Neuropathic Pain | Phase 3 | 2015-01-01 |
| Terminated | Open Label Study of DS-5573a Advanced Solid Malignant Tumors | Phase 1 | 2014-09-01 |
| Completed | Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 2 | 2014-07-01 |
| Completed | Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors Solid Tumors | Phase 1 | 2013-10-01 |
| Completed | Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Venous Thromboembolism | Phase 3 | 2012-03-01 |
| Completed | Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy Pain, Diabetic Peripheral Neuropathy | Phase 2 | 2012-01-01 |
| Completed | Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Rena Non-valvular Atrial Fibrillation | Phase 3 | 2011-11-01 |
| Completed | CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 1 | 2010-06-01 |
| Completed | CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer ( Carcinoma, Non-Small-Cell Lung | Phase 1 | 2010-03-01 |
| Completed | An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) Metastatic Colorectal Cancer | — | 2009-10-15 |
| Completed | An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer | — | 2009-10-15 |
| Completed | A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty Prevention, Venous Thromboembolism | Phase 3 | 2009-05-01 |
| Completed | A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Venous Thromboembolism | Phase 3 | 2009-03-01 |
| Completed | A Multinational Phase III Study of CS-8958 (MARVEL) Influenza, Human | Phase 3 | 2008-11-01 |
| Completed | Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery Venous Thromboembolism | Phase 3 | 2008-10-01 |
| Completed | A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty Venous Thromboembolism, Thromboembolism, Thrombosis | Phase 2 | 2008-07-01 |
| Completed | Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis Osteoporosis | Phase 3 | 2008-05-01 |
| Completed | DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation Atrial Fibrillation, Stroke | Phase 2 | 2007-10-01 |
| Completed | Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes Type 2 Diabetes | Phase 2 | 2007-08-01 |
| Completed | Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes Type 2 Diabetes | Phase 2 | 2007-07-01 |
| Completed | Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation Atrial Fibrillation | Phase 2 | 2007-03-01 |
| Completed | A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Venous Thromboembolism, Deep Vein Thrombosis, Total Knee Arthroplasty | Phase 2 | 2006-07-01 |
| Completed | Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension Hypertension | Phase 4 | 2005-02-01 |
| Completed | Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy Chronic Glomerulonephritis, Diabetic Nephropathy | Phase 2 | 2005-01-01 |
| Completed | ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial Diabetic Nephropathy, Type 2 Diabetes Mellitus, Proteinuria | Phase 3 | 2003-04-01 |